HUALAN BIOLOGICAL ENGINEERING INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.7 CNY | -0.61% |
|
+1.23% | -10.98% |
ETFs positioned on Hualan Biological Engineering Inc.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.73% | 4 M€ | -2.96% | ||
| 0.68% | 0 M€ | -12.95% | - | |
| 0.07% | 35 M€ | -5.85% | - | |
| 0.01% | 0 M€ | +3.30% | - | |
| 0.01% | 4 M€ | -4.41% | - | |
| 0.00% | 0 M€ | +8.46% | - | |
| 0.00% | 0 M€ | +7.05% | - | |
| 0.00% | 0 M€ | +5.36% | - | |
| 0.00% | 0 M€ | +5.99% | - | |
| 0.00% | 0 M€ | +4.28% | - | |
| 0.00% | 0 M€ | +8.16% | - | |
| 0.00% | 0 M€ | +7.51% | - | |
| 0.00% | 0 M€ | +3.53% | - | |
| 0.00% | 0 M€ | +4.81% | - | |
| 0.00% | 0 M€ | +5.64% | - | |
| 0.00% | 0 M€ | +3.44% | - | |
| 0.00% | 0 M€ | +2.65% | - | |
| 0.00% | 0 M€ | +0.56% | - | |
| 0.00% | 0 M€ | +14.03% | ||
| 0.00% | 0 M€ | +0.53% | - |
Hualan Biological Engineering, Inc. specializes in the research, development, manufacturing and marketing of biological and sanguine products and vaccines. The group's products include immunoglobulin for intravenous injections, lyophilized surgical fibrin, lyophilized thrombin for external use, vaccines against cold, etc.
Sector
Pharmaceuticals
Calendar
2024-08-27
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
19.7
CNY
Average target price
25.78
CNY
Spread / Average Target
+30.88%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -10.98% | 5.03B | |
| -2.47% | 88.14B | |
| +3.29% | 40.44B | |
| -15.40% | 32.24B | |
| +51.96% | 24.39B | |
| -14.35% | 15.59B | |
| -39.65% | 12.3B | |
| -6.52% | 12.18B | |
| -13.41% | 12.14B | |
| +5.17% | 8.87B |
- Stock Market
- Equities
- 002007 Stock
- Funds and ETFs Hualan Biological Engineering Inc.